A gut–liver axis governs the fate of drug delivery vectors

Abstract

An article in Science reports a previously unrecognized gut microbiota-driven endocrine circuit that maintains Kupffer cell activation, thereby dictating the systemic efficiency of therapies delivered by nanocarriers.